Keystone Clinical Studies LLC Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2003

Location

Plymouth Meeting PA US

Primary Industry

Pharmaceuticals

About

Founded in 2003 and based in Pennsylvania, US, Keystone Clinical Studies LLC operates as a provider of clinical trial services such as lab and medical research, patient testing and monitoring, data analysis and refinement, and FDA approval. Cherian Verghese is the founder and CEO of the company as of 2022. In October 2022, Flourish Research acquired Keystone Clinical Studies LLC. The company conducts Phase 2, 3, and 4 clinical trials for Alzheimer's Disease, Parkinson's Disease, and Depression. The firm helps to improve the lives of individuals, families, and communities through the development of new medications for neuropsychiatric disorders. Keystone's partners include Lilly, Allergan, Iqvia, Eisai, Syneos Health, Merck, and more.

Current Investors

Flourish Research

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.keystoneclinicals.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Deals

Deals Type
Add-on

Deal Status	Target (s)	Deal Date	Investor(s)	Seller(s)	Deal size (Mn)	Enterprise value (Mn)	Post-money valuation (Mn)	EBITDA multiple (x)	Revenue multiple (x)	Lead partner (s)
Completed	Keystone Clinical Studies LLC	07 Oct 2022

Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.